Chromosome Disorders  >>  arsenic trioxide  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
arsenic trioxide / Generic mfg.
NCT00081133: Arsenic Trioxide and Imatinib Mesylate in Treating Patients With Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Completed
1/2
US
arsenic trioxide, imatinib mesylate
Memorial Sloan Kettering Cancer Center, National Cancer Institute (NCI)
Leukemia
02/05
02/05

Download Options